AVITA Medical (RCEL) Equity Average (2019 - 2025)

AVITA Medical (RCEL) has 7 years of Equity Average data on file, last reported at -$11.7 million in Q4 2025.

• For the quarter ending Q4 2025, Equity Average fell 239.4% year-over-year to -$11.7 million; the trailing twelve-month figure through Dec 2025 stood at -$11.7 million (down 239.4% YoY), and the FY2025 full-year result was -$6.1 million, down 122.69% from the prior year.
• Equity Average for Q4 2025 stood at -$11.7 million, down from -$9.8 million in the prior quarter.
• Across five years, Equity Average topped out at $117.3 million in Q2 2021 and bottomed at -$11.7 million in Q4 2025.
• The 5-year median for Equity Average is $69.5 million (2023), against an average of $57.1 million.
• The widest annual swing landed in 2021, when Equity Average soared 72.78%; it then sank 239.4% in 2025.
• A 5-year view of Equity Average shows it stood at $108.1 million in 2021, then declined by 20.08% to $86.4 million in 2022, then tumbled by 35.14% to $56.0 million in 2023, then slumped by 85.07% to $8.4 million in 2024, then tumbled by 239.4% to -$11.7 million in 2025.
• The last three Equity Average figures came in at -$11.7 million (Q4 2025), -$9.8 million (Q3 2025), and -$8.7 million (Q2 2025), per Business Quant data.

Peer Comparison